Lv11
50 积分 2023-09-05 加入
Risk of infections in patients with pemphigus treated with rituximab vs. azathioprine or mycophenolate mofetil: a large-scale global cohort study
6天前
已完结
Response to Majeranowski
6天前
已完结
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial
23天前
已完结
Mycophenolate mofetil: An update
24天前
已完结
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial
25天前
已完结
Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial
25天前
已完结
Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial
25天前
已完结
Disease-modifying treatments for neuromyelitis optica spectrum disorder in the context of a new generation of biotherapies
27天前
已完结
Efficacy of low or heavy rituximab‑based protocols and comparison with seven regimens in idiopathic membranous nephropathy: a systematic review and network meta-analysis
1个月前
已完结
Optimizing Pemphigus Management With Rituximab and Short-Term Relapse Predictors
1个月前
已完结
皖公网安备34019202002308
